Clifford Schold

1.2k total citations
13 papers, 922 citations indexed

About

Clifford Schold is a scholar working on Genetics, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Clifford Schold has authored 13 papers receiving a total of 922 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 6 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Clifford Schold's work include Glioma Diagnosis and Treatment (8 papers), Brain Metastases and Treatment (5 papers) and Stress Responses and Cortisol (1 paper). Clifford Schold is often cited by papers focused on Glioma Diagnosis and Treatment (8 papers), Brain Metastases and Treatment (5 papers) and Stress Responses and Cortisol (1 paper). Clifford Schold collaborates with scholars based in United States, Canada and United Kingdom. Clifford Schold's co-authors include Gregory Cairncross, Dorcas Fulton, Doug Stewart, Terrence L. Cascino, David Macdonald, Samuel K. Ludwin, Edward J. Dropcho, Jan C. Buckner, Anthony J. Rothschild and Alan F. Schatzberg and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Clifford Schold

13 papers receiving 884 citations

Peers

Countries citing papers authored by Clifford Schold

Since Specialization

Citations

This map shows the geographic impact of Clifford Schold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clifford Schold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clifford Schold more than expected).

Fields of papers citing papers by Clifford Schold

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clifford Schold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clifford Schold. The network helps show where Clifford Schold may publish in the future.

Co-authorship network of co-authors of Clifford Schold

This figure shows the co-authorship network connecting the top 25 collaborators of Clifford Schold. A scholar is included among the top collaborators of Clifford Schold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clifford Schold. Clifford Schold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Phase II study of neoadjuvant 1, 3‐bis (2‐chloroethyl)‐1‐nitrosourea and temozolomide for newly diagnosed anaplastic glioma 2004 ·Cancer ·Susan M. Chang, Michael D. Prados, W.K. Alfred Yung, Howard A. Fine, Larry Junck, Harry S. Greenberg, H. Ian Robins, Minesh P. Mehta, Karen Fink, Kurt A. Jaeckle, John G. Kuhn, Kenneth R. Hess, Clifford Schold	40
2	Research involving the newly dead: An institutional response 2003 ·Critical Care Medicine ·Michael A. DeVita, Mark R. Wicclair, Dennis P. Swanson, (unknown), Clifford Schold	6
3	An open label trial of C-1073 (mifepristone) for psychotic major depression* 2002 ·Biological Psychiatry ·Joseph K. Belanoff, Anthony J. Rothschild, Frederick Cassidy, Charles DeBattista, Etienne-Emile Baulieu, Clifford Schold, Alan F. Schatzberg	229
4	Evaluating Glioma Therapies: Modeling Treatments and Predicting Outcomes 1995 ·JNCI Journal of the National Cancer Institute ·Sarah Kirby, (unknown), William Irish, (unknown), (unknown), Clifford Schold, Gregory Cairncross	18
5	Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group. 1994 ·Journal of Clinical Oncology ·Gregory Cairncross, David Macdonald, Samuel K. Ludwin, (unknown), Terrence L. Cascino, Jan C. Buckner, Dorcas Fulton, Edward J. Dropcho, Doug Stewart, Clifford Schold	335
6	Treatment of subcutaneous and intracranial brain tumor xenografts withO 6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea 1993 ·Cancer Chemotherapy and Pharmacology ·G. Michael Felker, (unknown), M. Eileen Dolan, Robert C. Moschel, Clifford Schold	67
7	Transient Late Magnetic Resonance Imaging Changes Suggesting Progression of Brain Stem Glioma: Implications for Entry Criteria for Phase II Trials 1988 ·Neurosurgery ·Darryl C. Longee, Henry S. Friedman, W T Djang, Edward C. Halperin, Clifford Schold, Jerry Oakes	7
8	Efficacy of Vincristine and Cyclophosphamide in the Therapy of Recurrent Medulloblastoma 1986 ·Neurosurgery ·(unknown), (unknown), Clifford Schold, Nicholas A. Vick, John M. Falletta, Dennis E. Bullard, (unknown), Janardan D. Khandekar, (unknown), Jerry Oakes, Darell D. Bigner	68
9	Intensive 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) monochemotherapy and autologous marrow transplantation for malignant glioma. 1986 ·Journal of Clinical Oncology ·G. L. Phillips, S N Wolff, JW Fay, R H Herzig, (unknown), Clifford Schold, (unknown)	68
10	Intracerebral Growth of a Human Glioma Tumor Line in Athymic Mice and Treatment with Procarbazine, 1,3-Bis(2-chloroethyl)-l-nitrosourea, Aziridinylbenzoquinone, and cis-Platinum 1983 ·Neurosurgery ·Clifford Schold, Charles E. Rawlings, Sandra H. Bigner, Darell D. Bigner	21
11	Experience Using Two CT-Guided Stereotactic Biopsy Methods 1983 ·Stereotactic and Functional Neurosurgery ·Dennis E. Bullard, Blaine S. Nashold, Dustin Osborne, (unknown), (unknown), Clifford Schold, W. Jerry Oakes, Alan H. Friedman, (unknown), Philip J. Dubois	4
12	How heterogeneous are gliomas? 1981 ·PubMed ·Bigner Dd, Clifford Schold, Bigner Sh, (unknown), (unknown)	23
13	Origin of Seizures in Elderly Patients 1977 ·JAMA ·Clifford Schold	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact